Nonetheless, all the peripheral blood samples in this study were acquired before 2022, and we still considered the DLBCL with MYC and BCL2 and/or BCL6 rearrangement as DHL/THL according to the 2016 World Health Organization classification of lymphoma. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.